2-propanol has been researched along with Prostatic Hyperplasia in 21 studies
2-Propanol: An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.
propan-2-ol : A secondary alcohol that is propane in which one of the hydrogens attached to the central carbon is substituted by a hydroxy group.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the effects of alfuzosin hydrochloride and tamsulosin hydrochloride on choroidal thickness (CT) and pupil diameter (PD) sizes in patients with benign prostatic hyperplasia." | 9.24 | The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases with Benign Prostatic Hyperplasia. ( Dogan, M; Halat, AO; Karalar, M; Keles, I; Kutluksaman, B, 2017) |
| "Intraoperative floppy-iris syndrome (IFIS) is a recently identified condition associated with phacoemulsification in patients using the alpha1-antagonist tamsulosin (Flomax)." | 7.73 | Preoperative use of atropine to prevent intraoperative floppy-iris syndrome in patients taking tamsulosin. ( Bendel, RE; Phillips, MB, 2006) |
| "To compare the effects of alfuzosin hydrochloride and tamsulosin hydrochloride on choroidal thickness (CT) and pupil diameter (PD) sizes in patients with benign prostatic hyperplasia." | 5.24 | The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases with Benign Prostatic Hyperplasia. ( Dogan, M; Halat, AO; Karalar, M; Keles, I; Kutluksaman, B, 2017) |
| "Each patient administered tamsulosin had a sluggish hypotonic iris, along with a tendency toward miosis and a tendency for prolapse of the iris into the phaco tunnel or into the side port during cataract surgery." | 3.73 | Influence of tamsulosin on the iris and its implications for cataract surgery. ( Dugué, B; Keski-Rahkonen, P; Lehtonen, M; Leppänen, E; Mauriala, T; Pärssinen, O, 2006) |
| "Intraoperative floppy-iris syndrome (IFIS) is a recently identified condition associated with phacoemulsification in patients using the alpha1-antagonist tamsulosin (Flomax)." | 3.73 | Preoperative use of atropine to prevent intraoperative floppy-iris syndrome in patients taking tamsulosin. ( Bendel, RE; Phillips, MB, 2006) |
| "To demonstrate a progressive approach to the problems of intraoperative floppy-iris syndrome (IFIS) in cataract surgery caused by tamsulosin." | 3.73 | Cataract surgery management in patients taking tamsulosin staged approach. ( Allen, D; Manvikar, S, 2006) |
| "Tamsulosin was currently used by 16 patients and in the past by 4 patients; the control group comprised 10 patients." | 1.40 | Effect of tamsulosin on iris vasculature and morphology. ( Cooney, TM; Elner, VM; Hood, CT; Hussain, MT; Shtein, RM, 2014) |
| "Patients' records were reviewed, and age, medical, surgical, and ocular history; gender; medications; and duration and dosage of tamsulosin were recorded." | 1.36 | The effect of alpha1-adrenergic receptor antagonist tamsulosin (Flomax) on iris dilator smooth muscle anatomy. ( Chang, DF; Destafeno, JJ; Kim, T; Proia, AD; Santaella, RM; Stinnett, SS, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (80.95) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dogan, M | 1 |
| Kutluksaman, B | 1 |
| Keles, I | 1 |
| Karalar, M | 1 |
| Halat, AO | 1 |
| Shtein, RM | 1 |
| Hussain, MT | 1 |
| Cooney, TM | 1 |
| Elner, VM | 1 |
| Hood, CT | 1 |
| Moretsky, SL | 1 |
| Prata, TS | 1 |
| Palmiero, PM | 1 |
| Angelilli, A | 1 |
| Sbeity, Z | 1 |
| De Moraes, CG | 1 |
| Liebmann, JM | 1 |
| Ritch, R | 1 |
| Friedman, AH | 1 |
| Santaella, RM | 1 |
| Destafeno, JJ | 1 |
| Stinnett, SS | 1 |
| Proia, AD | 1 |
| Chang, DF | 1 |
| Kim, T | 1 |
| González Martín-Moro, J | 1 |
| Sanz, FG | 1 |
| Munoz-Negrete, FJ | 1 |
| Pärssinen, O | 2 |
| Lawrentschuk, N | 1 |
| Bylsma, GW | 1 |
| Settas, G | 1 |
| Fitt, AW | 1 |
| Leppänen, E | 1 |
| Keski-Rahkonen, P | 1 |
| Mauriala, T | 1 |
| Dugué, B | 1 |
| Lehtonen, M | 1 |
| Mamalis, N | 1 |
| Bendel, RE | 1 |
| Phillips, MB | 1 |
| Manvikar, S | 1 |
| Allen, D | 1 |
| Lim, LA | 1 |
| Frost, A | 1 |
| Osher, RH | 1 |
| Lee, KJ | 1 |
| Figueira, EC | 1 |
| Sharma, NS | 1 |
| Masselos, K | 1 |
| Ooi, JL | 1 |
| Chan, DG | 1 |
| Francis, IC | 1 |
| Shugar, JK | 1 |
| Andersson, KE | 1 |
| Gratzke, C | 1 |
| Gallenga, PE | 1 |
| Lobefalo, L | 1 |
1 review available for 2-propanol and Prostatic Hyperplasia
| Article | Year |
|---|---|
Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system.
Topics: Adrenergic alpha-Antagonists; Animals; Cardiovascular System; Central Nervous System; Ejaculation; H | 2007 |
1 trial available for 2-propanol and Prostatic Hyperplasia
| Article | Year |
|---|---|
The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases with Benign Prostatic Hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Choroid; Color Vision; Diagnostic | 2017 |
19 other studies available for 2-propanol and Prostatic Hyperplasia
| Article | Year |
|---|---|
Effect of tamsulosin on iris vasculature and morphology.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Case-Control Studies; Cataract Extraction; Ciliary Ar | 2014 |
Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications.
Topics: Adrenergic alpha-Antagonists; Cataract Extraction; Humans; Iris; Male; Prostatic Hyperplasia; Sulfon | 2009 |
Iris morphologic changes related to alpha(1)-adrenergic receptor antagonists implications for intraoperative floppy iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Cross-Sectional Studies | 2009 |
Tamsulosin and the intraoperative floppy iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Cataract Extraction; Co | 2009 |
The effect of alpha1-adrenergic receptor antagonist tamsulosin (Flomax) on iris dilator smooth muscle anatomy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Anth | 2010 |
Tamsulosin and iris pigmentation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anthropometry; Cataract Extra | 2010 |
The use of tamsulosin and iris hypotony during cataract surgery.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Humans; Iri | 2005 |
Intraoperative 'floppy iris' syndrome and its relationship to tamsulosin: a urologist's guide.
Topics: Antineoplastic Agents; Humans; Iris; Iris Diseases; Male; Prostatic Hyperplasia; Sulfonamides; Tamsu | 2006 |
Cataract surgery may be complicated by prostate drugs.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Humans; | 2006 |
Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy.
Topics: Adrenergic alpha-Antagonists; Aged, 80 and over; Cataract Extraction; Humans; Intraoperative Complic | 2006 |
Influence of tamsulosin on the iris and its implications for cataract surgery.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Anti | 2006 |
Intraoperative floppy-iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Antineoplastic Agents; Humans | 2006 |
Preoperative use of atropine to prevent intraoperative floppy-iris syndrome in patients taking tamsulosin.
Topics: Adrenergic alpha-Antagonists; Atropine; Humans; Intraoperative Complications; Iris; Iris Diseases; M | 2006 |
Cataract surgery management in patients taking tamsulosin staged approach.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents, Non | 2006 |
Iris tears secondary to intraoperative floppy-iris syndrome associated with tamsulosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Intraoperative | 2006 |
Preoperative atropine in IFIS.
Topics: Adrenergic alpha-Antagonists; Antineoplastic Agents; Atropine; Humans; Intraoperative Complications; | 2007 |
Iris prolapse and the floppy-iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Antineoplastic Agents; Humans | 2007 |
Prophylaxis for IFIS.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Atropine; Cataract Extraction | 2007 |
Postoperative finding in the intraoperative floppy-iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Atrophy; Humans; Intrao | 2007 |